Allergan (AGN), Nektar (NKTR) Shares Lower After Hours as Traders Wonder Where's the MAP (MAPP) News...
Tweet Send to a FriendGet Alerts MAPP Hot Sheet
Trade MAPP Now!
Investors are still anxiously waiting for FDA news on MAP Pharma's (Nasdaq: MAPP) Levadex. As the stock was halted just ahead of 2pm ET, traders are using shares of partners Allergan (NYSE: AGN) and Nektar Therapeutics (Nasdaq: NKTR) as a way to play MAP. After closing at $7.87 this afternoon, Nektar shares are down about 3 percent to $7.62 after hours. Shares of Allergan, meanwhile, are down about 0.3 percent to $94.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
- Will Erickson Air-Crane (EAC) Stock Crash and Burn?
- UPDATE: Kansas City Southern (KSU) to Replace Dean Foods (DF) in S&P 500; WhiteWave Foods (WWAV) to S&P MidCap 400
Create E-mail Alert Related Categories
FDA, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
